Improving Uptake of Breast, Bowel and Cervical Cancer Screening Among Muslim Women: a Non-randomised Feasibility Study of a Peer-led, Faith-based Intervention

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this non-randomised trial is to test how a workshop that includes religiously-tailored messages can help increase the uptake of breast, colorectal and cervical cancer screening among Muslim women in North East England and Scotland. The results of this trial will inform the development of a full-scale randomised-controlled trial. Participants in this study will be asked to take part in a two-hour workshop, deliver either online or in-person.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 25
Maximum Age: 74
Healthy Volunteers: t
View:

• Women from any ethnicity identifying as Muslim

• Muslim Women aged 25-74 years

• Muslim women living in North East England or Scotland

• Muslim women who are not up-to-date with all cancer screening they are eligible for; women who are up-to-date with one type of screening but not others would be eligible (for example, women might be up-to-date with breast cancer screening but not cervical or bowel cancer screening)

Locations
Other Locations
United Kingdom
University of Glasgow
RECRUITING
Glasgow
University of Sunderland
RECRUITING
Sunderland
Contact Information
Primary
Floor Christie-de Jong
floor.christie@sunderland.ac.uk
0191 5153445
Backup
Rawand Jarrar
rawand.jarrar@sunderland.ac.uk
07940503640
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 200
Treatments
Experimental: In-person delivery
Participants will attend the workshops in a mosque or community centre.
Experimental: Online delivery
Participants will join the workshops via a web conferencing platform The content of the online workshops is identical to the content of in-person workshops.
Sponsors
Leads: University of Sunderland
Collaborators: University of Glasgow

This content was sourced from clinicaltrials.gov